DVL1 and metabolic dysfunction-associated steatohepatitis: In the present study, we suggest a new approach for improving NASH phenotypes by restoring the suppressed regenerative Wnt/β-catenin signaling by inhibiting CXXC5 function through either Cxxc5 knockout or CXXC5-Dvl PPI inhibition.